Tue, Jul 21, 2026
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Industry Updates

Dr. Craig Gordon launches alternative investment firm GordonMD Global Investments

Wednesday, September 08, 2021
Opalesque Industry Update, for New Managers - Craig Gordon, MD, a licensed physician with over a decade of buy-side experience managing global biopharmaceutical portfolios, has launched GordonMD Global Investments. The U.S.-based firm is focused on investments in private and publicly traded global growth and innovative biopharma companies primarily located in the U.S., Japan, and Europe.

GordonMD Global Investments stands apart from other equity managers, including those focused on biopharmaceutical or similar sector and industries. The firm's perspective is derived from Dr. Gordon's medical knowledge and training combined with his over 10 years of experience at The Capital Group, where he served as an Equity Investment Analyst, built and managed an on average over $7 billion AUM portfolio across various mandates, and assisted with oversight of additional multi-billion dollar AUM portfolios.

"The launch of GordonMD Global Investments is the culmination of my decades of experience as a portfolio manager, investment analyst and physician. At GordonMD Global Investments we employ my proprietary analysis to target truly innovative companies with best-in-class assets that move clinically with the potential not only to change the standard of care but also to generate outsized returns. The firm combines my medical and investing acumen to create a singular advantage for institutional and accredited high-net-worth investors," said Craig Gordon, MD, Founder, CEO, and CIO of GordonMD Global Investments.

Prior to establishing his own firm, Dr. Gordon worked at The Capital Group for 10+ years, where he was an Equity Investment Analyst and built his own portfolio and established a successful track record in Private Placements and with multiple fund mandates, including U.S. Growth, Global Growth and Small Cap. Prior to The Capital Group, he worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate. Dr. Gordon lives and works in Los Angeles but frequently visits management teams and attends conferences across the world. He earned an MBA from Duke University, a Doctor of Medicine from the University of Miami Miller School of Medicine, and a B.A. in Economics from Cornell University.

The firm's service providers include Jefferies, Bank of America, SS&C, Seward & Kissel LLP, Constellation Consulting Services LLC, and Goldman Sachs.


Press release
Bg

Article source - Opalesque is not responsible for the content of external internet sites

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Nvidia extraordinary growth and the challenge of sustaining demanding valuations over time[more]

    Antonio Di Giacomo, Senior Market Analyst at XS.com, writes: Nvidia has established itself as one of the most extraordinary growth companies in the global technology sector. Over the past two fiscal years, its revenues have risen from levels close to $60 billion annually to well above $120 billi

  2. Secondaries take center stage: What the 2026 PE landscape means for GPs and investors[more]

    Matthias Knab, Opalesque for New Managers: The 2026 edition of Dechert's Global Private Equity Outlook - "Signs of a Gradual Thaw" - marks a notable shift in industry sentiment. After years of compr

  3. And, finally: Time to share it with the people[more]

    From Newsoftheweird: Leavenworth, Washington, has become a tourist destination because of the Bavarian theme businesses have adopted there, NPR reported. One shop, the Leavenworth Nutcracker Museum, houses the world's largest nutcracker collection, thanks to 101-year-old Arlene Wagner. Wagner sta

  4. Opalesque Exclusive: Private Markets Evergreen Funds - An Insider's View[more]

    Matthias Knab, Opalesque for New Managers: Private Markets Evergreen Funds: What Investors Need to Know Before They Dive In The democratization of private markets is well underway. Structural barriers t

  5. Opalesque Exclusive: Governance, Scale, and Boutique Resilience in a Consolidating Hedge Fund Industry[more]

    Matthias Knab, Opalesque for New Managers: The hedge fund industry has undergone significant consolidation in recent years, with capital increasingly concentrated among large multi-strategy platforms. Yet boutique m